Jan 03, 2017 12:02 pm UTC| Business
RedHill and Concordia entered into an exclusive co-promotion agreement, granting RedHill certain U.S. promotion rights for Donnatal®Donnatal®1, Tablets and Elixir (syrup), is a prescription oral drug used with other drugs...
Philio-tech Launches New Line of Cutting-Edge ULE-Based IoT Devices
Jan 03, 2017 12:02 pm UTC| Business
The new devices leverage DSP Group's ULE and HDClear SoCs superb range, interference free and natural voice user interface (VUI) LOS ALTOS, Calif., Jan. 03, 2017 -- DSP Group®, Inc. (NASDAQ:DSPG), a leading global...
Philio-tech Launches New Line of Cutting-Edge ULE-Based IoT Devices
Jan 03, 2017 12:02 pm UTC| Business
The new devices leverage DSP Group's ULE and HDClear SoCs superb range, interference free and natural voice user interface (VUI) LOS ALTOS, Calif., Jan. 03, 2017 -- DSP Group®, Inc. (NASDAQ:DSPG), a leading global...
Philio-tech Launches New Line of Cutting-Edge ULE-Based IoT Devices
Jan 03, 2017 12:02 pm UTC| Business
The new devices leverage DSP Group's ULE and HDClear SoCs superb range, interference free and natural voice user interface (VUI) LOS ALTOS, Calif., Jan. 03, 2017 -- DSP Group®, Inc. (NASDAQ:DSPG), a leading global...
Jan 03, 2017 12:02 pm UTC| Business
TNX-102 SL, a Phase 3 Drug candidate, recently granted Breakthrough Therapy designation by the FDA Pivotal study in military-related PTSD to begin this quarter NEW YORK, Jan. 03, 2017 -- Tonix Pharmaceuticals...
Jan 03, 2017 12:02 pm UTC| Business
TNX-102 SL, a Phase 3 Drug candidate, recently granted Breakthrough Therapy designation by the FDA Pivotal study in military-related PTSD to begin this quarter NEW YORK, Jan. 03, 2017 -- Tonix Pharmaceuticals...
Jan 03, 2017 12:02 pm UTC| Business
TNX-102 SL, a Phase 3 Drug candidate, recently granted Breakthrough Therapy designation by the FDA Pivotal study in military-related PTSD to begin this quarter NEW YORK, Jan. 03, 2017 -- Tonix Pharmaceuticals...